Intralesional Ranibizumab on Pterygium Vascularity, Size and Recurrence Rate: a Pilot Study

• Status: Completed
• Trial end date: 2014-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the pterygium vascularity and size before and after intralesional ranibizumab injection and to evaluate its recurrence rate following pterygium excision surgery.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Universiti Sains Malaysia; University of Science Malaysia
• Treatments: Ranibizumab

Criteria

Inclusion Criteria:

• All patients with primary pterygium.

• Grade T3 (fleshy) pterygium.

Exclusion Criteria:

• Patients with other ocular surface disorders.

• Previous ocular surgery or trauma.

• History of systemic thromboembolic event.

• Pregnant women and lactating mother.